Switching away from a China-linked CDMO or supplier? Get 3 verified options in 5 working days.
Each option comes with a dated evidence file you can hand to QA, your board or a contracting officer. Free for buyers.
Or send your supplier list for a free exposure check
Why now
What you get, free
A shortlist in 5 working days: 3 qualified non-China options for your modality, scale and phase: biologics or small-molecule CDMO, API and key starting materials, oligonucleotides, peptides, bioprocess consumables and equipment, testing labs.
An evidence file for each option. Every fact has a source and a date:
- FDA registration and listing; inspection history and outcomes
- 483s, warning letters, import alerts and recalls (last 5 years)
- DMF or CEP status; EU GMP or PIC/S status where relevant
- Ownership chain and China ties: parent, major shareholders and affiliates, checked against public lists
- Tariff exposure for the plant's country (US Section 232)
Optional exposure check: send your current supplier list and we flag ownership ties to entities that are on, or may be added to, the relevant lists, as of the check date.
When OMB publishes the list we re-check every evidence file we have issued and tell you if anything changed.
How we're paid
You pay $0. If you buy, the supplier pays us a disclosed success fee after you have paid them. It is never added to your price, and every quote shows the supplier's price line by line. We never hold your money or the goods. Same checks for every supplier, no paid rankings.
Get my free shortlist
Questions
Will suppliers learn who we are?
Not until you agree to an introduction. Suppliers only see a description such as "a US biotech, antibody, phase 2".
Do you only cover CDMOs?
No: APIs and key starting materials, oligonucleotides, peptides, bioprocess consumables and equipment, and testing labs too.
Which countries do the options come from?
Wherever qualified capacity without China ties exists, often the US, EU, UK, Switzerland, Japan, Korea, Taiwan, India and Singapore.
Is this legal advice or a certification?
No. Evidence files are good-faith screening of public records and supplier documents. Your own qualification and legal review still apply. We never say a company is or will be on the list before OMB publishes it.
General information, not legal or regulatory advice. Sources: NDAA FY2026 section 851 (BIOSECURE Act, signed 18 December 2025); DoD Section 1260H list update, 8 June 2026; law-firm summaries from Baker McKenzie, Akin Gump and DLA Piper.